Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed250%
recruiting125%
not_yet_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

The INICIO-Guatemala Study

NCT07383428
recruitingnot_applicable

MISC-CBO to Improve the Mental Health of OVC in South Africa

NCT05943132
completednot_applicable

Caregiver Training to Prevent Konzo Disease in Children in Democratic Republic of Congo (DRC)

NCT04036708
completednot_applicable

MISC-CBO in Children Affected by HIV/AIDS

NCT04359043

Clinical Trials (4)

Showing 4 of 4 trials
NCT07383428Not Applicable

The INICIO-Guatemala Study

Not Yet Recruiting
NCT05943132Not Applicable

MISC-CBO to Improve the Mental Health of OVC in South Africa

Recruiting
NCT04036708Not Applicable

Caregiver Training to Prevent Konzo Disease in Children in Democratic Republic of Congo (DRC)

Completed
NCT04359043Not Applicable

MISC-CBO in Children Affected by HIV/AIDS

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4